Induction of immunological tolerance is classically conferred by the very early injection of antigens.'2 Especially significant in terms of the concept of tolerance were the experiments performed upon mice in the immediate neonatal period.3 4 Exposure to antigens earlier in life also leads to tolerance. For example, newborn animals are tolerant to transplacentally transmitted maternal immunoglobulin.5 However, there have been few recorded studies of induction of tolerance by intrauterine injection of the fetus, a study which we have performed here.
Our initial interest concerning tolerance centred upon early embryo aggregation derived mouse chimaeras.6 7 Derivation of such chimaeras is difficult and this led us to consider 'constructing' chimaeras by intrauterine injection. Motivation for this approach was the possibility of using this procedure to correct certain haemopoietic stem cell defects, for example, thalassaemia major. In this study we have attempted to ascertain whether unresponsiveness to intrauterine injected xenogeneic whole blood and allogeneic bone marrow can be achieved and whether unresponsiveness is permanent.
Materials and methods

ANIMALS AND PRIMARY EXPERIMENTAL PROCEDURE
Tolerance to xenogeneic whole blood Tolerance was investigated in a litter of NZW rabbits and one rhesus monkey (Macaca mulatta) which was available. Although the surgical techniques employed for the two species varied, the approach was essentially the same. Briefly, this
Received for publication 18 June 1982. involved the injection of xenogeneic whole blood (human) into the peritoneal cavity of mid-late term rabbit and rhesus monkey fetuses and later challenging after birth.
Surgery in the rhesus monkey was performed as described by Cotes and her colleagues8 and involved hysterotomy, removal ofamniotic fluid, and injection of whole human blood (2 to 4 ml ip) through a 23 gauge needle into the fetus under direct vision. The incision was later repaired in layers. Before closure, amniotic fluid with 10 ml of warm saline was introduced back into the amniotic cavity.
Laparotomy in the rabbit was followed by injection of human blood directly through the uterine wall into the peritoneal cavity of each fetus, using a 23 gauge needle, and the abdominal wall was repaired in layers as in the monkey. Thirteen fetuses were injected with 0 5 ml group A Rh+ve human blood on the 28th day of a 31 day gestation. One monkey fetus was injected at 90 days with 2 to 4 ml ofA Rh+ve human whole blood. In each case following the first challenge each animal was rechallenged once radioactivity could no longer be detected in any of the animals.
Results
XENOGENEIC HUMAN BLOOD INJECTED ANIMALS
In both the rabbits and the rhesus monkeys there was a rapid and total loss (4 days) of 51Cr-radiolabelled red cells and there was no difference between the in utero injected animals and the untreated matched controls. This loss, one has to presume, resulted from interspecies human red cell lytic activity in both the rabbits and monkeys.
In respect of the results with labelled HSA both the rabbits and monkey presented very similar findings.
The results on the rabbits are detailed in seen in the sole in utero injected monkey which was tested. No apparent difference could be demonstrated between the in utero injected and control monkey following the 1st HSA challenge, but clear differences were seen in the 2nd, 3rd, 4th, and 5th challenges. Although only performed in two animals the fact remains that the overall pattern (fig 2) is very similar to the rabbits (fig 1) . In both the test and control group of rabbits and monkeys a very rapid clearance of HSA was noted during the first 24 hours. This is assumed to be the result of elimination of denatured radiolabelled HSA. In contrast to the in utero injected unresponsive (tolerant) animals, the rapid elimination (post 24 hour) 'fall off' in the control animals is presumed to be the result of increasing sensitisation to HSA challenges. It might be argued that we only examined one in utero injected monkey (and one untreated control). However, the data are included here (1) to record the remarkable similarity with the situation in the rabbits and (2) to show that the phenomenon is not confined to the rabbit but also occurs in other species, species nearer to man, which clearly, the red cell survival was increased almost four-fold in the intrauterine grafted animals, and it must be assumed that the relative accelerated loss of labelled red cells in controls represents immune clearance. Tolerance to at least the donor red cell must be assumed to result from intrauterine bone marrow grafting.
Discussion
Fetal blood sampling is currently being employed in the diagnosis of various human blood diseases and perhaps the commonest is thalassaemia major.9 Our primary interest in tolerance to in utero grafts is the possibility of correction of such diseases by midgestational grafting of normal adult haematopoietic stem cells. Hopefully these cells will survive and, for example, in the case of thalassaemia major, proliferate and provide erythroid cells with normal haemoglobin. Even if the primary graft is not established, there is always the opportunity of a secondary graft in the postnatal period, since we anticipate having achieved tolerance. In this context it is of interest to note the findings of Rayfield and his colleagues.10 They showed that whereas lymphoid cells obtained from the human fetus before 18 weeks of in utero life were capable of reacting in an MLR, cytoxicity could not be demonstrated. This is encouraging in respect to fetal grafting in humans at around 16 weeks' gestation, the time at which diagnosis ofthalassaemia is usually performed. The implication is that the graft would be accepted and hopefully the child would be rendered tolerant. Here it would be an advantage to use the parents as stem cell graft donors. If 
